U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Qian, Jun ^a   Yao, Dong ming ^a   Lin, Jiang ^a   Qian, Wei ^a   Wang, Cui zhu ^a   Chai, Hai yan ^a   Yang, Jing ^a   Li, Yun ^a   Deng, Zhao qun ^a   Ma, Ji chun ^a   Chen, Xing xing ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL NUCLEAR RIBONUCLEOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHINESE; CHRONIC MYELOID LEUKEMIA; CODON; COHORT ANALYSIS; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEMODYNAMIC PARAMETERS; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MYELODYSPLASTIC SYNDROME; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; SURVIVAL TIME; U2AF1 GENE;

ADULT; AGED; AGED, 80 AND OVER; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION, MISSENSE; MYELODYSPLASTIC SYNDROMES; NUCLEAR PROTEINS; PROGNOSIS; RIBONUCLEOPROTEINS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84866552418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045760     Document Type: Article

References (26)

1. Huntly BJ, Gilliland DG, (2005) Cancer biology: summing up cancer stem cells. Nature 435: 1169-1170.
2. Jordan CT, Guzman ML, Noble M, (2006) Cancer stem cells. N Engl J Med 355: 1253-1261.
3. Döhner H, Gaidzik VI, (2011) Impact of genetic features on treatment decisions in AML. Hematology Am Soc Hematol Educ Program 2011: 36-42.
4. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al., eds. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press.
5. Zamore PD, Green MR, (1991) Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution. Embo J 10: 207-214.
6. Black DL, (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
7. Baralle D, Baralle M, (2005) Splicing in action: assessing disease causing sequence changes. J Med Genet 42: 737-748.
8. Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, et al. (2011) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 44: 53-57.
9. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, et al. (2011) Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478: 64-69.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. (1985) Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625.
11. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, et al. (2000) Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 96: 4075-4083.
12. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088.
13. Qian J, Lin J, Yao DM, Chen Q, Xiao GF, et al. (2010) Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform. Clin Chim Acta 410: 2097-2100.
14. Lin J, Yao DM, Qian J, Chen Q, Qian W, et al. (2011) Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 6: e26906.
15. Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, et al. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98: 1752-1759.
16. Szankasi P, Jama M, Bahler DW, (2008) A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electropheresis. J Mol Diagn 10: 236-241.
17. Lin J, Yao DM, Qian J, Chen Q, Qian W, et al. (2011) Recurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. PLoS One 6: e26906.
18. Lin J, Yao DM, Qian J, Chen Q, Qian W, et al. (2012) IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Ann Hematol 91: 519-525.
19. Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, et al. (2012) Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119: 3203-3210.
20. Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, et al. (2012) Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119: 3578-3584.
21. Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, et al. (2012) Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 119: 3211-3218.
22. Grosso AR, Martins S, Carmo-Fonseca M, (2008) The emerging role of splicing factors in cancer. EMBO Rep 9: 1087-1093.
23. David CJ, Manley JL, (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24: 2343-2364.
24. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, et al. (2007) Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8: 349-357.
25. Ding WQ, Kuntz SM, Miller LJ, (2002) A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced sellular U2AF35 and a suboptimal 3′-splicing site leading to retention of the fourth intron. Cancer Res 62: 947-952.
26. Pacheco TR, Moita LF, Gomes AQ, Hacohen N, Carmo-Fonseca M, (2006) RNA interference knockdown of hU2AF35 impairs cell cycle progression and modulates alternative splicing of Cdc25 transcripts. Mol Biol Cell 17: 4187-4199.